AU7918798A - A medicament useful for the treatment of post-menopausal syndrome and osteoporosis, and for reducing fat mass and increasing lean body mass - Google Patents

A medicament useful for the treatment of post-menopausal syndrome and osteoporosis, and for reducing fat mass and increasing lean body mass

Info

Publication number
AU7918798A
AU7918798A AU79187/98A AU7918798A AU7918798A AU 7918798 A AU7918798 A AU 7918798A AU 79187/98 A AU79187/98 A AU 79187/98A AU 7918798 A AU7918798 A AU 7918798A AU 7918798 A AU7918798 A AU 7918798A
Authority
AU
Australia
Prior art keywords
osteoporosis
post
treatment
mass
lean body
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU79187/98A
Inventor
Tiziano Camponovo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SUNNIMEX Ltd
Original Assignee
SUNNIMEX Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SUNNIMEX Ltd filed Critical SUNNIMEX Ltd
Publication of AU7918798A publication Critical patent/AU7918798A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU79187/98A 1997-06-11 1998-06-05 A medicament useful for the treatment of post-menopausal syndrome and osteoporosis, and for reducing fat mass and increasing lean body mass Abandoned AU7918798A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI97A1372 1997-06-11
IT97MI001372A IT1292129B1 (en) 1997-06-11 1997-06-11 USEFUL MEDICATION FOR REDUCE FAT MASS AND INCREASE LEAN MASS IN WOMEN IN MENOPAUSE AND IN BOTH SEXES IN
PCT/EP1998/003392 WO1998056386A1 (en) 1997-06-11 1998-06-05 A medicament useful for the treatment of post-menopausal syndrome and osteoporosis, and for reducing fat mass and increasing lean body mass

Publications (1)

Publication Number Publication Date
AU7918798A true AU7918798A (en) 1998-12-30

Family

ID=11377337

Family Applications (1)

Application Number Title Priority Date Filing Date
AU79187/98A Abandoned AU7918798A (en) 1997-06-11 1998-06-05 A medicament useful for the treatment of post-menopausal syndrome and osteoporosis, and for reducing fat mass and increasing lean body mass

Country Status (3)

Country Link
AU (1) AU7918798A (en)
IT (1) IT1292129B1 (en)
WO (1) WO1998056386A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004200178B2 (en) * 1998-06-11 2006-10-26 Endorecherche, Inc. Pharmaceutical Compositions and Uses for Androst-5-ene-3B,17B-diol
TR200102867T2 (en) 1998-06-11 2002-06-21 Endorecherchel@Inc
US20030119800A1 (en) * 2001-06-18 2003-06-26 Manolagas Stavros C. Bone anabolic compounds and methods of use
US8703751B2 (en) 2009-11-09 2014-04-22 The Regents Of The University Of California Androstenediol as an indicator for assessing estrogenicity

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5719197A (en) * 1988-03-04 1998-02-17 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5116828A (en) * 1989-10-26 1992-05-26 Nippon Zoki Pharmaceutical Co., Ltd. Pharmaceutical composition for treatment of osteoporosis
US5641768A (en) * 1989-11-17 1997-06-24 Loria; Roger M. 5-androstene 3β, 17β diol for treatment
US5183815A (en) * 1991-01-22 1993-02-02 Merck & Co., Inc. Bone acting agents
US5206008A (en) * 1991-04-15 1993-04-27 Virginia Commonwealth University Enhancement of immune response
US5387583A (en) * 1993-04-20 1995-02-07 Loria; Roger M. Compositions containing corticosteroids or analogues thereof and corticosteroid buffering effective amounts of 5-androstene 3B, 17B or 5-androstene 3B, 7B, 17B triol or analogues thereof
US5478566A (en) * 1993-09-29 1995-12-26 Loria; Roger M. Stimulation of cytokine production

Also Published As

Publication number Publication date
ITMI971372A0 (en) 1997-06-11
IT1292129B1 (en) 1999-01-25
WO1998056386A1 (en) 1998-12-17
ITMI971372A1 (en) 1998-12-11

Similar Documents

Publication Publication Date Title
HK1030753A1 (en) Fracture healing using pthrp analogs.
AU3560495A (en) Medicament inhaler
IL130027A (en) Rosiglitazone - glyburide synergistic combinations for treatment of diabetes
HK1020956A1 (en) Oxadiazoles, processes for their preparation and their use as medicaments
HUP9901089A3 (en) Medical splint
GB2279879B (en) Medicament inhalers
IL119894A (en) Use of thiazolidine in the preparation of a medicament for the treatment of osteoporosis
AU1986099A (en) Device for inhaling medicament
GB9418064D0 (en) Medicament administration inhaler
HUP9904075A3 (en) Composition, for the treatment of asthma,containing loratadine and a decongestant
AU3105095A (en) Device for ensuring that medication is taken at the correct time
IL135511A0 (en) 2-arylbenzo[b] thiophenes useful for the treatment of estrogen deprivation syndrome
AU7918798A (en) A medicament useful for the treatment of post-menopausal syndrome and osteoporosis, and for reducing fat mass and increasing lean body mass
AU4636396A (en) Antiglucocorticoid medicament
AU6582098A (en) Medical splint product
HUP0103569A2 (en) New medicament and process for its preparation
EP0724842A3 (en) Preparation for the treatment of obesity
AU4107797A (en) Compounds for the treatment and prevention of diabetes
EP1207895A4 (en) Peptide and peptide analogues for the treatment and prevention of diabetes
AU1237495A (en) Organopathy preventing, curing or ameliorating agent
AU8561998A (en) Cyclic compounds and medicinal use thereof
GB2341319B (en) Use of compounds in the preparation of a medicament for the therapeutic treatment of a wasting syndrome
AUPO861697A0 (en) An improved splint for finger and toe fractures
CA75178S (en) Medicament inhalation device
GR940100324A (en) Therapeutic vaporized mixture and method for the preparation and use thereof.

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase